Clinical Trial: Activity Monitoring Assessment of Opiate Withdrawal


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Activity Monitoring Assessment of Opiate Withdrawal - 4

This study has been completed.

Sponsored by:	National Institute on Drug Abuse (NIDA) VA-Washington, DC
Information provided by:	National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

Treatment or Intervention	Phase
Drug: Morphine	Phase II

MedlinePlus consumer health information

Study Type: Interventional
Study Design: Treatment, Uncontrolled

Official Title: Activity Monitoring Assessment of Opiate Withdrawal

Eligibility

Ages Eligible for Study: 21 Years - 55 Years, Genders Eligible for Study: Male

Criteria

Please contact site for information.

Location Information

District of Columbia
Washington DC VA, Washington, District of Columbia, 20422, United States

Study chairs or principal investigators

Steven Deutsch, M.D., Principal Investigator, VA-Washington, DC

More Information

Study ID Numbers: NIDA-3-0009-4
Record last reviewed: December 2002
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000335
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-20

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services